Diaminopimelate decarboxylase from Mycobacterium tuberculosis (LysA, DAPDC, Rv1293) has been cloned and heterologously expressed in Escherichia coli, purified using standard chromatographic techniques and crystallized. Preliminary diffraction data analysis suggests the presence of a homotetramer in the asymmetric unit.
Introduction
Recently, the enzymes of the lysine-biosynthetic pathway have drawn considerable attention as potential targets for new antibacterial drugs and herbicides (Hutton et al., 2003) . In both plants and bacteria, the lysine-biosynthetic pathway starts from l-aspartate and leads to l-lysine in nine enzymatically catalysed steps. The final step in this pathway is carried out by the enzyme diaminopimelate decarboxylase (LysA, DAPDC), which converts meso-diaminopimelate (DAP) to lysine in a PLP-dependent decarboxylation reaction. The crystal structures of DAPDC from Escherichia coli in complex with PLP and with PLP and lysine have been determined (Momany et al., 2002;  V. Levdikov, L. Blagova, N. Bose & C. Momany, unpublished results; PDB entries 1knw and 1ko0), as have the crystal structures of the enzyme from Methanococcus jannaschii in complex with a substrate analogue as well as in complex with PLP and lysine (Ray et al., 2002 ; PDB entries 1twi and 1tuf). More recently, the crystal structure of the Mycobacterium tuberculosis enzyme has been determined in complex with lysine as well as in complex with both PLP and lysine (Gokulan et al., 2003; PDB entries 1hkv and 1hkw) . The biologically active unit of DAPDC appears to be a homodimer consisting of two domains per subunit. For the enzyme from M. tuberculosis, domain 1 is a (/) 8 -barrel consisting of residues 48-308, whereas domain 2 is a -sandwich consisting of residues 1-47 and 309-446 (Gokulan et al., 2003) . The two active sites per dimer are located at the subunit interface and are made up from residues of both domains. In the case of the DAPDC-PLP complex, PLP is covalently attached to the amino group of Lys73 (M. tuberculosis DAPDC numbering). All of the DAPDC structures reported so far are structures of the enzyme in complex with either the cofactor or a substrate analogue or the product lysine, meaning that the structure of the free enzyme, required for a more complete structural analysis, has still to be elucidated. Here, we report the crystallization of the apoenzyme of M. tuberculosis DAPDC in a new crystal form and preliminary X-ray diffraction investigation of this crystal form.
Experimental methods

Cloning
Genomic DNA from the H37Rv strain of M. tuberculosis was used as the template for the polymerase chain reaction. The following oligonucleotides (Invitrogen) were used as forward and reverse primers, respectively: 5 0 -GGGGCATATGGCTGTGAACGAGCTG-CTGCACTTAGCGCCGAATGTGTGG-3 0 and 5 0 -GGGGAAG-CTTACCTCGTGGTACACCCCTCACTTCCAAACTCAGCAAA-TCGTCGACCGTCTCCC-3 0 . In the forward primer the GCT triplet coding for Ala (underlined) was introduced as the second codon to increase the efficiency of expression (Looman et al., 1987) . In the reverse primer a thrombin-cleavage site (underlined) was introduced. The amplified fragment containing 5 0 -NdeI and 3 0 -HindIII restriction sites (in bold) was cloned into the pCR-BluntII-TOPO vector (Invitrogen). After sequence confirmation, the insert was subcloned into the pET22b expression vector (Novagen), which adds a His 6 tag to the expressed recombinant protein. Both the pCR-BluntII and the final pET22b constructs were sequenced to confirm the cloning of the lysA gene sequence.
Expression and purification
The recombinant plasmid was used to transform E. coli BL21 Star (DE3) pRARE cells. These cells were prepared by transforming BL21 Star (DE3) cells (Invitrogen) with the pRARE plasmid isolated from the Rosetta strain (Novagen). Cells from an overnight 5 ml preculture were grown in LB broth medium containing chloramphenicol (30 mg ml
À1
) and ampicillin (50 mg ml
) at a temperature of 310 K and shaken at 200 rev min
. The culture was induced with 0.25 mM isopropyl -d-thiogalactopyranoside (IPTG) at an OD 600 of approximately 0.6 at 293 K. Following induction, the culture was incubated for about 15 h at 293 K and 220 rev min À1 and then harvested. The cells were frozen and stored at 193 K until further processing. 1 g of cell pellet was dissolved in 10 ml buffer A [20 mM Tris pH 8.0, 250 mM NaCl, 10 mM imidazole, 5%(v/v) glycerol], 3 mM -mercaptoethanol (-ME) and one Complete Mini EDTAfree Protease Inhibitor Cocktail tablet (Roche) per 30 ml and then lysed by sonication for 3 Â 5 min in 0.4 s pulses at 277 K. The cell debris was pelleted by centrifugation for 60 min at 277 K and 20 000 rev min À1 . The crude lysate was filtered through a 0.22 mm membrane and loaded onto a 5 ml Hi-Trap Chelating HP column charged and equilibrated with Ni 2+ and buffer A, respectively. In order to remove unbound proteins, the column was first washed with five column volumes of buffer A, then with five column volumes of buffer B [20 mM Tris pH 8.0, 1 M NaCl, 10 mM imidazole, 5%(v/v) glycerol, 2 mM -ME] and finally with three column volumes of buffer C [20 mM Tris pH 8.0, 250 mM NaCl, 50 mM imidazole, 5%(v/v) glycerol, 2 mM -ME]. The protein was eluted by running a linear gradient from 50 to 800 mM imidazole (in buffer C). The major peak fractions were pooled and dialyzed against buffer D [20 mM Tris pH 8.0, 250 mM NaCl, 5%(v/v) glycerol, 5 mM EDTA, 5 mM -ME]. The protein was subsequently purified by gel filtration (Superdex 200, 16/60) using buffer E [20 mM Tris pH 8.0, 250 mM NaCl, 5%(v/v) glycerol, 5 mM DTT] for both equilibration and elution. The protein eluted with an apparent molecular weight of approximately 100 kDa, which is consistent with a homodimer. The peak fractions were analyzed by SDS-PAGE, pooled and concentrated to 6 mg ml À1 . Both columns used for purification were supplied by Amersham Pharmacia Biotech. SDS-PAGE and dynamic light scattering were used to assess the chemical and conformational purity of the protein, respectively.
Crystallization
Recombinant DAPDC with an additional Ala residue in position 2 and the C-terminal extension GVPRGKLAAALEHHHHHH was crystallized using the hanging-drop vapour-diffusion method (2 ml protein solution and 2 ml reservoir solution) in the presence of 20-23%(w/v) polyethylene glycol monomethylether 5000, 0.1 M MES pH 6.1-6.6 and 60 mM ammonium sulfate. Crystals appeared within a week and grew to a maximum size of 300 Â 300 Â 300 mm. They diffract X-rays to about 2.2 Å resolution.
Diffraction data collection and processing
For data collection, a crystal was quickly immersed in reservoir solution containing 20%(v/v) MPD and flash-cooled to 100 K in a nitrogen stream. Diffraction data were then collected on the X11 beamline (EMBL Hamburg, Germany) using a MAR CCD detector. The data were indexed and integrated using DENZO (Otwinowski & Minor, 1997) and scaled using SCALEPACK (Otwinowski & Minor, 1997) . The redundancy-independent merging R factor R r.i.m. as well as the precision-indicating merging R factor R p.i.m. (Weiss, 2001) were calculated using the program RMERGE (available from http:// www.embl-hamburg.de/~msweiss/projects/msw_qual.html or from MSW upon request). The relevant data-collection and processing parameters are given in Table 1 . Intensities were converted to structure-factor amplitudes using the program TRUNCATE (French & Wilson, 1978; Collaborative Computational Project, Number 4, 1994) . The optical resolution of the data set was calculated using the program SFCHECK (Vaguine et al., 1999) . Calculation of the selfrotation function was carried out using the program MOLREP (Collaborative Computational Project, Number 4, 1994) and structure-factor amplitudes to a maximum resolution of 4.0 Å .
Results and discussion
A single crystal of LysA from M. tuberculosis grown under the conditions described above is shown in Fig. 1 Figure 1 Crystal of LysA from M. tuberculosis.
was not required for successful LysA crystallization, which is in contrast to the findings reported by Gokulan et al. (2003) , who only managed to crystallize LysA in the presence of lysine. Moreover, if crystallization was attempted in the presence of lysine, only poorly diffracting crystals (d min = 6 Å or less) were obtained. Despite the fact that the crystallization conditions resemble very much those reported by Gokulan et al. (2003) , the space group and unit-cell parameters are very different and seemingly unrelated ( Table 1) . The reason for this is probably the longer C-terminal extension and the extra Ala residue at position 2 of the polypeptide chain construct used in this study. The crystals also do not exhibit a distinctly yellow colour; it is therefore likely that the apoprotein has been crystallized. Based on the molecular weight of the polypeptide and the volume of the unit cell, it is most likely that four molecules are present in the asymmetric unit. This would correspond to a Matthews parameter of 2.5 Å 3 Da À1 and a solvent content of 51%. Since the biological unit of LysA is a dimer, it may therefore be expected that the four molecules in the asymmetric unit occur as two homodimers. However, the selfrotation revealed the presence of three distinct peaks on the = 180 section (Fig. 2) . This is inconsistent with two separate homodimers, but suggests that a homotetramer of D 2 symmetry is present in the asymmetric unit. Since the protein eluted as an apparent dimer from the gel-filtration column, it may be that the homotetramer is really a dimer of dimers and that the formation of the tetramer is a consequence of the crystallization conditions. The exact nature and architecture of the LysA tetramer present in this crystal form will have to await the determination of the three-dimensional structure.
Conclusion
The protein LysA from M. tuberculosis has been heterologously expressed in E. coli and purified to homogeneity. Crystals grown in the absence of substrate or cofactor are colourless and appear to contain one homotetramer of LysA in the asymmetric unit.
